Safety and preliminary efficacy of vimseltinib in tenosynovial giant cell tumor (TGCT)

Simple item page
dc.conference.dateSEP 16-21, 2021
dc.conference.titleCongress of the European-Society-for-Medical-Oncology (ESMO)
dc.contributor.authorGelderblom, H.
dc.contributor.authorRazak, A. R. Abdul
dc.contributor.authorSanchez-Gastaldo, A.
dc.contributor.authorRutkowski, P.
dc.contributor.authorWilky, B.
dc.contributor.authorWagner, A.
dc.contributor.authorvan de Sande, M.
dc.contributor.authorMichenzie, M.
dc.contributor.authorVallee, M.
dc.contributor.authorSharma, M.
dc.contributor.authorSherman, M. L.
dc.contributor.authorRuiz-Soto, R.
dc.contributor.authorTap, W.
dc.contributor.authoraffiliation[Gelderblom, H.] Leids Univ Med Ctr LUMC, Med Oncol, Leiden, Netherlands
dc.contributor.authoraffiliation[Razak, A. R. Abdul] Princess Margaret Canc Ctr, Toronto Sarcoma Program, Toronto, ON, Canada
dc.contributor.authoraffiliation[Sanchez-Gastaldo, A.] Hosp Univ Virgen Rocio, Med Oncol Dept, Phase 1 Unit, Seville, Spain
dc.contributor.authoraffiliation[Rutkowski, P.] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Soft Tissue Bone Sarcoma & Melanoma, Warsaw, Poland
dc.contributor.authoraffiliation[Wilky, B.] Univ Colorado, Canc Ctr, Dept Med Med Oncol, Aurora, CO USA
dc.contributor.authoraffiliation[Wagner, A.] Dana Farber Canc Inst, Sarcoma Ctr, Med Oncol, Boston, MA 02115 USA
dc.contributor.authoraffiliation[van de Sande, M.] Leiden Univ, Med Ctr, Dept Orthoped, Leiden, Netherlands
dc.contributor.authoraffiliation[Michenzie, M.] Deciphera Pharmaceut LLC, Dept Clin Res, Waltham, MA USA
dc.contributor.authoraffiliation[Sharma, M.] Deciphera Pharmaceut LLC, Dept Clin Res, Waltham, MA USA
dc.contributor.authoraffiliation[Sherman, M. L.] Deciphera Pharmaceut LLC, Dept Clin Res, Waltham, MA USA
dc.contributor.authoraffiliation[Ruiz-Soto, R.] Deciphera Pharmaceut LLC, Dept Clin Res, Waltham, MA USA
dc.contributor.authoraffiliation[Vallee, M.] Deciphera Pharmaceut LLC, Dept Biostat, Waltham, MA USA
dc.contributor.authoraffiliation[Tap, W.] Mem Sloan Kettering Canc Ctr, Med Oncol, 1275 York Ave, New York, NY 10021 USA
dc.contributor.funderDeciphera Pharmaceuticals, LLC
dc.date.accessioned2025-01-07T15:33:02Z
dc.date.available2025-01-07T15:33:02Z
dc.date.issued2021-09-21
dc.identifier.doi10.1016/j.annonc.2021.08.275
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.annonc.2021.08.275
dc.identifier.urihttps://hdl.handle.net/10668/27231
dc.identifier.wosID700527703363
dc.issue.number5
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.page.numberS1233-S1234
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleSafety and preliminary efficacy of vimseltinib in tenosynovial giant cell tumor (TGCT)
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number32
dc.wostypeMeeting Abstract

Files

Collections

SAS - Hospital Universitario Virgen del Rocío

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía